µÚËÄÒ½¿Æ´óѧ1998ÄêÃâÒßѧ£¨×¨»ù£©£¨²©Ê¿£© 4^? J BpBZ
l}#z#L2,`
Ò»¡¢Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© #5Zf6w
1¡¢Co-stimulators (or co-stimulating molecules) R^nkcLFb/q
2¡¢NK-kB i/Nd
3¡¢Immunoglobulin superfamily \5k^zGF4o
4¡¢antigen-presenting cell (APC) ^CZ)!3qd1
5¡¢death domain d;Uzl1;
6¡¢CCR and CXCR '[XtARtY`
7¡¢Lectin (or mitogen) _t9@
vVQ
8¡¢Clusters of differentiation, CD) <Z8I#IPl
9¡¢B7 family Z$8X1(o
10¡¢Cytotoxic T lymphocyte, CTL) #D{jNSB
11¡¢IL-15 and IL-15 receptor (IL-15R) 6"
s}<
12¡¢MHC restriction `#X\@?'5
13¡¢Affinity-chromatography d"7l<
y5
14¡¢Cyctosprin A, CsA p4ML }q8
15¡¢Antibody-dependent cell-mediated cytotoxicity, ADCC) ~ jR:oN
";I|\ T
¶þ¡¢¼ò´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© \xQ10\u
1¡¢ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 yAge2m]<B
2¡¢ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØϵ¡£ =bVaB<!
3¡¢ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌص㡣 Z+zx*(X
ql|ksios
Èý¡¢ÎÊ´ðÌ⣨25·Ö£© ?5%0zMC
1¡¢Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ E7XFt#P.
ѪҺ²¡Ñ§×¨Òµ£º J9tQ@3{f
2¡¢ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎΪÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿